Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › IL-12 immunotherapy for cancer

IL-12 immunotherapy for cancer

US Patent 10258653 · Granted Apr 16, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD30 and anti-CD3 bispecific antibodies and methods of immunotherapy for CD2025
Anti-CD30 antibodies2025
Use of lentivector-transduced T-Rapa cells for amelioration of lysosomal storage2025
T-Rapa cells as novel effector cell type for chimeric antigen receptor therapy2024
Recombinant PD-L1 peptides and methods of use2024
CD30 bispecific antibodies and method of immunotherapy of CD30+ malignancies2023
In vitro and in vivo enrichment strategy targeting lymphocytes derived from vect2023
Anti-CD30 antibodies and methods for treating CD30+ cancer2023
Thymidylate kinase fusions and uses thereof2018
IL-12 immunotherapy for cancer2018
IL-12 immunotherapy for cancer2018
Thymidylate kinase fusions and uses thereof2016